Cambridge Innovation Capital

📍 London, Großbritannien
🏷️ vc
Website besuchen ↗
Investitionsthese

Cambridge Innovation Capital (CIC) focuses on investing in knowledge-intensive businesses, specifically in life sciences and deep tech, within the Cambridge ecosystem. Their investment strategy centers on identifying and supporting entrepreneurs with groundbreaking ideas that have the potential to transform lives and achieve global impact. CIC leverages its unique relationship with the University of Cambridge and its network of entrepreneurs, research institutes, and accelerators to gain early access to promising startups. They aim to provide financial backing and expert guidance to enable these pioneers to build world-leading companies. CIC aims to be a leading Series A investor, capitalizing on its privileged access to the University of Cambridge's innovative ideas and talent. They are driven by a passion for science and its ability to drive change. The firm seeks to invest in companies with the potential for both financial success and positive societal impact. They believe that prioritizing impact and ESG (Environmental, Social, and Governance) factors will enhance long-term financial returns. Their approach includes actively engaging with portfolio companies to incorporate ESG principles into their operations. CIC demonstrates leadership by working with partners in the innovation ecosystem to accelerate the integration of impact and ESG considerations. They have a dedicated Responsible Investment report which highlights their progress, learnings, and the link between ESG and value creation within their portfolio. Ultimately, Cambridge Innovation Capital aims to foster innovation and create a positive impact by investing in and supporting companies that are developing cutting-edge technologies and solutions in life sciences and deep tech. They emphasize a combination of scientific knowledge, commercial expertise, and a commitment to sustainability.

Investitionsphase
Series A, Growth funding

Bevorzugte Reifephase für die erste Finanzierung.

Sektoren & Themen

Life Sciences, Deep Tech

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.

Ticketgröße
€18.560.000 - €69.000.000

Standard-Finanzierungsbetrag pro Runde.

Outreach & Dossier-Analysen

Verifiziertes E-Mail-Muster

[email protected] | [email protected]

Analysen-Scorecard der Investitionsthese

Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...

Verifizierte Partnerkontakte freischalten

Finde verifizierte E-Mail-Vorlagen, direkt von der KI verfasste Outreach-Texte und berechne Übereinstimmungen mit 1 Klick.

Kostenloses Konto erstellen

Dauert weniger als 30 Sekunden · Keine Kreditkarte erforderlich